TOKYO -- Domestic COVID drugs are arriving in Japan and South Korea, providing more treatment options for doctors fighting against the omicron wave of COVID cases.
Pharmaceuticals
Japanese and South Korean COVID treatments belatedly arrive
Starting from behind, companies go up against global competition and new variants
re.jpg?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto)
A trial run of oral COVID-19 treatment pills at a drugstore in Incheon, South Korea, on Jan. 12, two days before the government began allowing the medication, starting with patients who have a weak immune system or are over the age of 65. © EPA/Jiji
Read Next
Latest on Pharmaceuticals
